EXTENDED DURATION DUAL ANTIPLATELET THERAPY AND MORTALITY – A SYSTEMATIC REVIEW AND META-ANALYSIS

BACKGROUND: Treatment with the combination of aspirin and a P2Y12 inhibitor is commonly employed in a number of cardiovascular conditions. The overall impact of such treatment on all-cause mortality is unknown. In the Dual Antiplatelet Therapy (DAPT) Study, an international multicenter randomized pl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet
Autors principals: Elmariah, Sammy, Mauri, Laura, Doros, Gheorghe, Galper, Benjamin Z., O’Neill, Kelly E., Steg, Philippe Gabriel, Kereiakes, Dean J., Yeh, Robert W.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386690/
https://ncbi.nlm.nih.gov/pubmed/25467565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(14)62052-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars